ORAMED PHARMACEUTICALS INC.

ORMP

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001176309

SEC filings (opens in a new tab)

Insider trades, last 90 days

0 buys · 2 sells

Sold $942.17K
Open-market purchases (P) and sales (S), counted by Form 4 filing.

View insider trades

13F holders, Q2 2026

84

+20 vs. Q1 2026
Total value $80.67M

View 13F holders

Superinvestors holding ORMP

0

None of the superinvestors held ORMP at the end of Q2 2026.

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by ORMP insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Jul 2, 20265:00 PM ET	Jul 1, 2026	Hexter JoshuaCOO & CBO	SSaleCommon Stock	−137K	$4.463	−$611.43K	1.02M	−11.8%	SEC
Jul 2, 20265:00 PM ET	Jul 1, 2026	Gabay AvrahamChief Financial Officer	SSaleCommon Stock	−73.36K	$4.5085	−$330.74K	671.79K	−9.8%	SEC
Apr 4, 2023	Apr 3 – Apr 4, 2023	Mayer ArieDirector	PPurchaseCommon Stock	+8.81K	$2.2157	+$19.52K	26.81K	+48.9%	SEC
Mar 16, 2023	Mar 16, 2023	KIDRON NADAVPresident and CEO	PPurchaseCommon Stock	+26K	$2.04	+$53.04K	126K	+26.0%	SEC
Mar 15, 2023	Mar 14, 2023	KIDRON NADAVPresident and CEO	PPurchaseCommon Stock	+100K	$2.01	+$201K	100K	New position	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in ORMP at the end of Q2 2026.

Institutions holding ORMP in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
MERCER GLOBAL ADVISORS INC /ADV	3,810,540	$18.33M	0.02%	+1,900,000+99.4%	Added
Aquamarine Financial (Cayman) Ltd	2,512,175	$12.08M	0.67%	+399,863+18.9%	Added
Gem Investment Advisors, LLC	1,998,802	$9.61M	5.90%	+358,733+21.9%	Added
BlackRock, Inc.	1,608,111	$7.74M	0.00%	+1,515,919+1,644.3%	Added
Murchinson Ltd.	1,290,294	$6.21M	3.00%	−25,000−1.9%	Reduced